Effects of Global SGLT2 Knockout on Heart Failure with Preserved Ejection Fraction

被引：0
|
作者：
Fain, Margaret E. [1 ]
Misener, Sol [1 ]
Zhou, Yalu [1 ]
Rousselle, Thomas [2 ]
Mas, Valeria R. [2 ]
Quaggin, Susan E. [1 ]
机构：
[1] Northwestern Univ, Feinberg Sch Med, Chicago, IL USA
[2] Univ Maryland, Sch Med, Baltimore, MD USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2024年 / 35卷 / 10期
关键词：
D O I：
10.1681/ASN.2024sr4k42qt
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
SA-PO278
引用
收藏
页数：2
相关论文
共 50 条
  • [1] SGLT2 Inhibitors and Heart Failure with Preserved Ejection Fraction
    Jhund, Pardeep S.
    HEART FAILURE CLINICS, 2022, 18 (04) : 579 - 586
  • [2] SGLT2 Inhibitors in Older Adults with Heart Failure with Preserved Ejection Fraction
    Julie Hias
    Laura Hellemans
    Karolien Walgraeve
    Jos Tournoy
    Lorenz Van der Linden
    Drugs & Aging, 2022, 39 : 185 - 190
  • [3] Sglt2 Inhibitors And The Clinical Conundrum Of Heart Failure With Preserved Ejection Fraction
    Sridhar, C.
    Krithika, C.
    JOURNAL OF PHARMACEUTICAL NEGATIVE RESULTS, 2022, 13 : 2200 - 2204
  • [4] SGLT2 Inhibition in Heart Failure with Preserved Ejection Fraction - The New Frontier
    Aguiar-Neves, Ines
    Santos-Ferreira, Diogo
    Fontes-Carvalho, Ricardo
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2023, 24 (01)
  • [5] Retrospective analysis of SGLT2 inhibitors in heart failure with preserved ejection fraction
    Clemmer, John S.
    Ward, Taylor J.
    Lirette, Seth T.
    ESC HEART FAILURE, 2023, 10 (03): : 2010 - 2018
  • [6] SGLT2 Inhibitors in Older Adults with Heart Failure with Preserved Ejection Fraction
    Hias, Julie
    Hellemans, Laura
    Walgraeve, Karolien
    Tournoy, Jos
    Van der Linden, Lorenz
    DRUGS & AGING, 2022, 39 (03) : 185 - 190
  • [7] Emerging Horizons in Heart Failure with Preserved Ejection Fraction: The Role of SGLT2 Inhibitors
    Heath, Rebecca
    Johnsen, Hakon
    Strain, W. David
    Evans, Marc
    DIABETES THERAPY, 2022, 13 (02) : 241 - 250
  • [8] Uric Acid and SGLT2 Inhibition With Empagliflozin in Heart Failure With Preserved Ejection Fraction
    Doehner, Wolfram
    Anker, Stefan D.
    Butler, Javed
    Zannad, Faiez
    Filippatos, Gerasimos
    Coats, Andrew J. S.
    Ferreira, Joao Pedro
    Henrichmoeller, Ingrid
    Brueckmann, Martina
    Schueler, Elke
    Pocock, Stuart J.
    Januzzi, James L.
    Packer, Milton
    JACC-HEART FAILURE, 2024, 12 (12) : 2057 - 2070
  • [9] Potential Mechanisms of SGLT2 Inhibitors for the Treatment of Heart Failure With Preserved Ejection Fraction
    Pabel, Steffen
    Hamdani, Nazha
    Singh, Jagdeep
    Sossalla, Samuel
    FRONTIERS IN PHYSIOLOGY, 2021, 12
  • [10] Are SGLT2 inhibitors effective against 'all' heart failure with preserved ejection fraction?
    Hasegawa, Koji
    Lewis, Basil S.
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2022,
12345